Results 221 to 230 of about 499,109 (301)
Adolescents' discourse on the consumption of psychoactive substances in schools. [PDF]
Vasconcelos KNF +7 more
europepmc +1 more source
Abstract Background and aims The market for new psychoactive substances (NPS) is highly dynamic, with hundreds of substances emerging on the European drug market in the last decade. 3‐methylmethcathinone (3‐MMC), a synthetic cathinone and isomer of mephedrone (4‐MMC), gained popularity in the Netherlands due to its psychostimulant effects and initial ...
Nadia Robert Petronella Wilhelmina Hutten +4 more
wiley +1 more source
Legislating novel psychoactive substances: lessons from 15 years of UK mortality data (2007-2022). [PDF]
Rock KL, Treble R, Copeland CS.
europepmc +1 more source
The association between job loss and alcohol and tobacco use
Abstract Aims This study used Australian longitudinal data to examine the effect of being fired or made redundant on alcohol and tobacco use. Design and setting Fixed effect panel analyses of 19 waves of the Household Income and Labour Dynamics in Australia (HILDA) survey, a voluntary representative longitudinal survey of over 17 000 Australians ...
Don Weatherburn, Sergey Alexeev
wiley +1 more source
New psychoactive substances: a multidisciplinary review of challenges and their diverse character. [PDF]
Marandiuc IM +6 more
europepmc +1 more source
Abstract Background and aims This study qualitatively explored psychological change processes as described by participants and therapists within a phase 2a clinical trial evaluating the safety, tolerability, and preliminary efficacy of a single dose of intranasal 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT; BPL‐003) administered alongside psychological
Mathieu Seynaeve +6 more
wiley +1 more source
Determinants of HIV Testing Uptake Among People Who Use New Psychoactive Substances in Kazakhstan: A Multi-Regional Cross-Sectional Study. [PDF]
Kuanyshbekova R +8 more
europepmc +1 more source
Abstract Background and Aims The introduction of prescribed medical cannabis in many parts of the world raises issues regarding how we conceptualise Cannabis Use Disorders (CUD). The Diagnostic Statistical Manual Version 5 (DSM5) provides a framework for ‘Prescription Cannabis Use Disorder’ (Pr‐CUD) when a person is using medical cannabis only‐as ...
Nicholas Lintzeris, Llewellyn Mills
wiley +1 more source
Global Patterns of Fatalities With Toxicological Detection of Novel Psychoactive Substances: A Systematic Review and Meta-analysis. [PDF]
Tyagi S +8 more
europepmc +1 more source
Abstract Background and aims Use of derived intoxicating cannabinoid products (DICPs) has grown in the United States (US), as have associated poisonings, emergency department visits and psychotic episodes. Brand marketing on social media, a largely underregulated marketing channel, may be contributing to this growth.
Kathryn La Capria +10 more
wiley +1 more source

